Pansoft Company Limited (NASDAQ:PSOF) advanced 21.09% up to $6.66 on news the energy technology company posted better than expected 2009 Q4 results this morning.  Highlights of the report include a jump of 47% for total revenues up to $4.9 million, from $3.3 million for the same quarter in 2008.  Gross profits increased 56% to $2.6 million, compared to $1.7 million for 2008 Q4. Diluted earnings per share were $0.36, up 64% compared to $0.22 for the fourth quarter 2008. Headquartered in Jinan, China, Pansoft Company Limited provides software solutions and services the petrol and gas industry in China. Its proprietary software provides support for business operations, including accounting; order processing; shipping; invoicing; inventory control; logistics and customer relationship management.

Hyperdynamics Corporation (AMEX:HDY) gained 7.58% up to $0.710 on no news; however last week the energy company extended terms of  a letter of intent  sent to Spanish energy company Repsol YPF. In addition, Repsol has agreed to pay Hyperdynamics $2.7 million for its share of work performed on the company’s ongoing 2-D seismic program. Repsol will also pay its share of the remaining work on the program, estimated to be valued at approximately $1.0 million, upon its completion. These funds can be repaid to Repsol at its option if the Production Sharing Agreement clarification has not been authorized by September 10, 2010.  Hyperdynamics recently closed their deal with Dana Petroleum in which Dana acquired exclusive rights to a 23% participating interest in Hyperdynamics’ concession offshore of the Republic of Guinea in exchange for US $19.6 million. Headquartered in Sugar Land, Texas, Hyperdynamics Corporation, through its subsidiaries, engages in the exploration and production of oil and gas offshore of the Republic of Guinea, West Africa and holds the largest exploration license in West Africa, covering 31,000 square.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

Bank of America Corporation (NYSE:BAC) slid  -3.70% to $14.95  on 140,138,194 shares on news the New York Attorney general has filed charges against Bank of America and Ken Lewis its former CEO, contending the bank defrauded investors when it acquired Merrill Lynch in 2008.  It has been alleged the Wall Street bank’s senior chief executives opted out of disclosing the true condition of Merrill Lynch’s substantial losses to shareholders before the vote to merger; then threatened to pull out of the merger if it didn’t get dozens of billions of dollars of bailout money, funded by US taxpayers.

The Attorney general said Bank of America’s actions were “egregious and reprehensible” in attempt to fool shareholders, and the US federal government.  The bank has reportedly received a total $45 billion in bailout funds, which in part helped to compensate losses from the Merrill Lynch acquisition. The Bank of America paid its top employees $4 billion dollars in bonuses for 2009.

Headquartered in Charlotte, North Carolina, Bank of America Corporation, is a financial holding company for one of the world’s largest financial institutions, offering individual consumers, small- and middle-market businesses and  corporations banking, asset management, insurance products and other financial and risk management services. On January 1, 2009, Bank of America announced the purchase of Merrill Lynch & Co., Inc.

 To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

AmeriChip International Inc. (OTC:ACII) gained  33.33% to close at $0.0004 on no news. AmeriChip International Inc is an innovative designer, developer and manufacturer of video and audio microchip products. ACII’s technological operations involve lasers to condition the metal chip. One of the company’s lead products is the very first ever high quality video and audio to print technology which requires readers to watch video with sound content from printed material. The micro thin video screen is applied to printed matter i.e. magazines and is robust enough to withstand binding and even the US postal delivery service. The company has business activities serving various markets including automobiles; oil production and refining; aerospace; off-road construction; farm implements manufacturing; defence, and wind energy.

Trans-Lux Corporation (AMEX:TLX) jumped 42.25% to close at $1.45 on no news, but surged on heavy volume. Headquartered in Norwalk, Connecticut, Trans-Lux Corporation is an integrated multimedia company serving diverse communications environments. The company manufactures, distributes, sells, leases, and services for programmable electronic information displays. Its advertisements include text, graphics, and video displays for various segments, including stock and commodity exchanges, financial institutions, college and high school sports stadiums, schools, casinos, convention centers, corporate, government, theatres, retail sites, airports, and billboard sites.

 To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

GeoPharma, Inc. (NASDAQ:GORX) gained 28.38% up to $0.501, on no news but surging on heavy volume. Headquartered in Largo, Florida, GeoPharma researches, develops, manufactures, and brings to market branded generic pharmaceuticals, veterinary products, health products, and functional foods.  The company is registered with both the Food and Drug Administration and the Drug Enforcement Administration.

GenVec, Inc. (NASDAQ:GNVC) jumped 32.64% up to $3.17 with 8,374,308 shares actively trading this afternoon, on news the company revealed remarkable long term survival analysis in patients with advanced oesophageal cancer.  GenVec presented the conclusive data at the American Society of Clinical Oncology’s 2010 Gastrointestinal Cancer Symposium in Orlando today. The innovative procedure applies endoscopy and endoscopic ultrasound  guided fine needle injection of their proprietary antitumor agent, the result was a median survival of 47.7 months; compared to historical clinical trials in similar stage disease with median survival rates of only 9.7 to 34 months. Gaithersburg, Maryland, GenVec, Inc., GenVec, Inc. a clinical stage biopharmaceutical company developing gene-based therapeutic drugs and vaccines in the US. The company’s pipeline includes TNFerade biologic, currently under Phase III trial for first-line treatment of inoperable, locally advanced pancreatic cancer; and TNFerade biologic, for the treatment of various cancers, including oesophageal cancer, rectal cancer, and head and neck cancer.

 To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

Somaxon Pharmaceuticals Inc. (NASDAQ:SOMX) blasted 102.27% up to $2.67 on news the sleep drug maker has refilled with the FDA seeking  approval for its New Drug Application (NDA)  on behalf of  Silenor (doxepin) for the treatment of insomnia.

On December 7^th 2009, the FDA declined Silenor for the second time that year; the stock spiralled down some 72% by mid-December, where it was trading around $0.928.  Fortunately the clinical safety of the drug was not an issue for the FDA; however the government agency was not satisfied with the efficacy standard for sustained sleep required to maintain effectiveness in adults with insomnia. 

Undaunted,  Somaxon  filed  ‘Class 1 resubmission’ this week and is prepared to begin commercialization of the drug candidate pending the decision, which is expected in about 8 weeks.

Somaxon currently has a market cap of about $62 million which is more than sufficient to finance its operations throughout the FDA’s current review of the Silenor and throughout the second quarter of 2010; and as of September 30^th 2009 the company had no debt. Headquartered in San Diego, California, Somaxon is a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the central nervous system such as insomnia.

 To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

This stock is up 71% this month - The big boys love this company and so do we - PTM expect a rally to push the stock past $5.00

EXP (http://www.canadianshieldresources.com/s/Home.asp) closed @ $1.76 on Friday.  The stock has been on a steady climb since the start of this month.

http://www.stockscores.com/quickreport.asp?ticker=v.exp

The buyers are piling into the stock in a big way because of the solid news flow.

December 7, 2009

Cdn Shield to peruse database for new Peru properties

http://www.stockwatch.com/newsit/newsit_newsit.aspx?bid=Z-C%3aEXP-1670887&symbol=EXP&region=C

December 16, 2009

Cdn Shield arranging $1.8-million private placement

http://www.stockwatch.com/newsit/newsit_newsit.aspx?bid=Z-C%3aEXP-1673791&symbol=EXP&region=C

The company is going after some big gold targets in Peru and if they come up aces the stock could go nuts.  Arequipa and Consolidated Stikine are good examples of exploration home runs.

Arequipa was a junior miner in Peru.  The stock traded at pennies before they hit it big which led to a takeover over by Barrick Gold Corp. (http://www.barrick.com/) on the NYSE..

http://www.nytimes.com/1996/08/30/business/for-canada-s-brash-young-mining-companies-that-pot-gold-may-depend-acquisitions.html

Consolidated Stikine is the ultimate example of how good things can get if you hit the mother lode when exploring for gold. The stock rose an incredible 70,000% and the stock price stuck.  Investors who got in early made a fortune.

 http://www.stockhouse.com/Blogs/ViewDetailedPost.aspx?p=1919

The smart money in EXP leads us to believe that they are betting that EXP will find something noteworthy.

One of the big shareholders in EXP is Rick Rule (http://www.gold-speculator.com/appenzell-daily-bell/12956-rick-rule-value-mining-companies-future-precious-metals.html).  He has a sizeable position.  This is a buy signal for PTM.

The stock keeps rising despite the recent placement.  This is another big buy signal.  Investors are willing to pick stock out of the market at a much higher price just to be in the game.

There are so many reasons to buy EXP.  We think members should get into EXP before the price moves to $5.00.  PTM thinks the break higher will come sooner than later.

Please remember to do your due diligence on EXP..

For more information on EXP, please join us @ www.picksthatmove.com. 

QAD Inc. (NASDAQ:QADI) climbed 29.88% up to $5.65 on news the company released fiscal 2010 Q3 results late yesterday.  QAD showed resilience during the most severe global economic downturn since the Great Depression, reporting small declines from one year ago; with stable growth trends over the last nine months.  Revenue narrowed to $56.2 million for the third quarter, from $67.8 million for the same period last year, and up from $51.3 million for the fiscal 2010 second quarter.  The company successfully mitigated the economic climate by decreasing total operating expenses to $28.1 million, from $37.1 million for the third quarter of last year. Headquartered in Santa Barbara, California, QAD Inc. is a software company providing professional services and application support for manufacturing companies.  QAD has long term business alliances with Progress Software Corporation and Microsoft Corporation.  The company’s software is used for logistics and supply chain operations which allow for facilitated management of inventories, fulfilment, performance management, reporting, budgets etc.

InfoSonics Corporation (NASDAQ:IFON) jumped 33.21% up to $1.41 on no news with volume quadrupling today.  Headquartered in San Diego, California, InfoSonics Corporation designs software for the telecommunication market and distributes wireless handsets and accessories in Latin America. The company provides sales, marketing and customer support though its sales offices and facilities throughout Latin America, including Argentina, El Salvador, Guatemala, Chile, and Colombia.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

ARCA biopharma, Inc. (NASDAQ:ABIO) skyrocketed 88.89%  up to $4.25 on news the US Food and Drug Administration has selected its drug Gencaro for a Fast Track development program. The FDA is investigating the drug for the reduction of cardiovascular mortality and cardiovascular hospitalization in a genotype-defined heart failure population. The drug candidate could begin clinical trial by late 2010.  Headquartered in Broomfield, Colorado, ARCA Biopharma Inc. is a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases in the US.

TLC Vision Corporation (USA) (NASDAQ:TLCV) jumped 22.73% up to $2.70 on no official news. Based in Mississauga, Ontario, TLC Vision Corporation is an eye care services company providing care directly to patients and as a partner with their doctors and facilities. The company owns and operates refractive centers which offer laser treatments for common refractive vision disorders such as myopia, hyperopia and astigmatism.   According to the corporate website, the company generates approximately $300 million in annual business activity.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

Kimber Resources, Inc. (AMEX:KBX) jumped 21.95% up to $1.00 on news the company announced an upgraded estimate of their mineral resources at their Monterde project, located in Mexico’s Sierra Madre mining district.  The update identifies a high grade gold-silver mineral deposit, with improved mining.  According to the company’s corporate press release, the new mineral resource estimate was based on 329 tests and identified that gold equivalent recoveries were 96% for indicated mineral resources and inferred mineral resources, silver recovery was 72% for indicated mineral resources and 75% for inferred mineral resources.  Headquartered in Vancouver, British Columbia, Kimber Resources Inc. engages in the acquisition, exploration, and development of mineral resource properties in Mexico. Kimber explores for gold and silver deposits and owns100% of the Monterde property including the Monterde Concessions, the El Coronel Concessions, and the Staked Concessions located in the state of Chihuahua, Mexico.  Kimber stock has gained 100% since January.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

Calgary, Alberta - PicksThatMove.com opines promising trading opportunities with likely potential for gain. The companies we follow have favourable revenue models for business development at upward cycles.  Please visit us at PicksThatMove.com to view more of our profiled stocks.

Mixed Signals In Healthcare: ETRM, LJPC Swing Gains

The hot stock information of the day includes:  ETRM, LJPC

EnteroMedics Inc. (NASDAQ:ETRM) jumped 21.25% up to $0.631 at midday on no news; however following dismal Q3 results last Friday which reported a net loss of $12.0 million, or $0.40 per share and disappointing preliminary findings in a key clinical trial assessing its anti-obesity device Maestro System, the company announced it will sack 40% of its workforce  - a total of 33 people will be terminated  by November 15, 2009.  Headquartered in St. Paul, Minnesota EnteroMedics Inc is a development stage medical device company designing, testing and developing devices that use neuron-blocking technology to cure obesity and treat other gastrointestinal disorders.  The company’s lead proprietary technology is designed to intermittently block a specific nerve using electrical impulses.  The Maestro System applies a limit to the expansion of the stomach to control hunger sensations between meals and produce a feeling of early and prolonged fullness.

La Jolla Pharmaceutical Company (NASDAQ:LJPC) soared 41.48% up to $0.0880 on no news; however the embattled biopharmaceutical company will hold a special stock holders meeting on Friday, October 30th to vote on a Plan of Complete Liquidation and Dissolution. If the proposal is approved, the company would expect to dissolve shortly after the stockholders’ meeting and begin liquidation to satisfy remaining creditor obligations and distribute any remaining cash once the dissolution is complete.  As of August 31, 2009, La Jolla Pharmaceutical had cash, net of liabilities and obligations of roughly $4.4 million.  After projected operating and shut down costs, the company projects that there will be between $0.028 and $0.045 per share available for distribution to holders of the approximately 66 million shares of common stock issued and outstanding stock.  While the La Jolla Pharmaceutical is seeking stockholder approval for the dissolution, the company expects to maintain its listing on the NASDAQ; however if the dissolution is not completed by November 6th, they expect that NASDAQ will take action at that time to commence proceedings to delist the company’s common stock.  Based in San Diego, California, La Jolla Pharmaceutical is a biopharmaceutical company focused on the discovery and development of small molecule therapy for the treatment of autoimmune diseases, and acute and chronic inflammatory disorders and acute and chronic inflammatory disorders such as Lupus.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock.